Evan Kearns
CIK: 0001745285
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cogent Biosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Dec 26, 2025COGT
Cogent Biosciences, Inc.
Sale(S)Direct65K shares at avg. $38.70$2.5M - Dec 17, 2025COGT
Cogent Biosciences, Inc.
Award(A)Direct40K shares- - Dec 17, 2025COGT
Cogent Biosciences, Inc.
Award(A)Direct260K shares- - Dec 17, 2025COGT
Cogent Biosciences, Inc.
Tax Payment(F)Direct125.6K shares at avg. $39.45$5.0M - Jan 23, 2025COGT
Cogent Biosciences, Inc.
Award(A)DirectStock Option (Right to Buy)
230K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 26, 2025 | COGT Cogent Biosciences, Inc. | Sale(S) | 65,000 | $38.70 | $2,515,500 | Direct |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Award(A) | 40,000 | - | - | Direct |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Award(A) | 260,000 | - | - | Direct |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Tax Payment(F) | 125,602 | $39.45 | $4,954,999 | Direct |
| Jan 23, 2025 | COGT Cogent Biosciences, Inc. | Award(A) Stock Option (Right to Buy) | 230,000 | - | - | Direct |
1-5 of 5 transactions
About Kearns Evan
Kearns Evan (SEC CIK 0001745285) files insider reports with the SEC as Chief Legal Officer of Cogent Biosciences, Inc. (COGT).
Signal8 holds 3 ownership filings by Kearns Evan, all Form 4s, filed between Jan 27, 2025 and Dec 30, 2025. Those filings report 5 transactions, from Jan 23, 2025 to Dec 26, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Kearns Evan's filings is in WALTHAM, MA.
Recent filings by Kearns Evan
Other insiders filing for Cogent Biosciences, Inc. (COGT)
- Ferrante Karen Jean, Director
- Harwin Peter Evan, Director
- CAIN CHRISTOPHER W., Director
- Shegog Todd, Director
- Morris Arlene, Director
- Ros Matthew, Director